Table 3.
Model | AIC | Deviance | d.f. | p |
---|---|---|---|---|
Early neurologic improvement | ||||
W/LSA-term | 100.16 | 88.157 | 80 | |
W/o LSA-term | 110.03 | 100.03 | 81 | 0.0005708 |
Discharge mRS≤2 | ||||
W/p LSA-term | 89.457 | 77.457 | 76 | |
W/o LSA-term | 10.044 | 90.438 | 77 | 0.0003147 |
Day 90 mRS≤2 | ||||
W/LSA-term | 73.13 | 61.313 | 66 | |
W/o LSA-term | 83.529 | 73.529 | 67 | 0.0004739 |
Note: The Akaike information criterion and deviance is displayed stratified according to two distinct predictions models, one including the variable LSA-sign+ vs. LSA-sign− (LSA-term) and one without the LSA term. Both models included age, admission NIHSS, reperfusion grade, final infarct volume and time to treatment. Data are displayed for three different clinical endpoints (early neurologic improvement, defined as difference between admission and discharge NIHSS ≥8 or discharge NIHSS ≤ 1, modified Rankin scale at discharge ≤2 and modified Ranking scale at day 90 ≤ 2). The p value refers to the comparison of deviance between the model including the LSA-term and the model excluding the LSA-term.
mRS: modified Rankin scale, W/: with; w/o: without; AIC: Akaike information criterion; d.f.: degrees of freedom.